Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A single center's experience of the extrapulmonary neuroendocrine carcinomas.
Celik E, Samanci NS, Derin S, Bedir S, Degerli E, Oruc K, Oztas NS, Alkan G, Senyigit A, Turna ZH. Celik E, et al. Among authors: oruc k. North Clin Istanb. 2021 Feb 14;9(1):35-40. doi: 10.14744/nci.2021.47887. eCollection 2022. North Clin Istanb. 2021. PMID: 35340315 Free PMC article.
The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy: A single-center experience.
Değerli E, Derin S, Oruç K, Şengül Samancı N, Bedir Ş, Çelik E, Şentürk Öztaş N, Alkan G, Demirelli FH, Demirci NS. Değerli E, et al. Among authors: oruc k. J Med Virol. 2021 Oct;93(10):5839-5845. doi: 10.1002/jmv.27123. Epub 2021 Jun 12. J Med Virol. 2021. PMID: 34081337 Free PMC article.
Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.
Tural D, Ölmez ÖF, Sümbül AT, Artaç M, Özhan N, Akar E, Çakar B, Köstek O, Ekenel M, Erman M, Coşkun HŞ, Selçukbiricik F, Keskin Ö, Türköz FP, Oruç K, Bayram S, Yılmaz U, Bilgetekin İ, Yıldız B, Şendur MAN, Paksoy N, Dirican A, Erdem D, Selam M, Tanrıverdi Ö, Paydaş S, Urakçı Z, Atağ E, Güncan S, Ürün Y, Alkan A, Kaya AO, Özyükseler DT, Taşkaynatan H, Yıldırım M, Sönmez M, Başoğlu T, Gündüz Ş, Kılıçkap S. Tural D, et al. Among authors: oruc k. Eur Urol Focus. 2021 Sep;7(5):1061-1066. doi: 10.1016/j.euf.2020.09.010. Epub 2020 Sep 30. Eur Urol Focus. 2021. PMID: 33008789
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.
Tural D, Ölmez ÖF, Sümbül AT, Özhan N, Çakar B, Köstek O, Ekenel M, Erman M, Coşkun HŞ, Selçukbiricik F, Keskin Ö, Türköz FP, Oruç K, Bayram S, Bilgetekin İ, Yıldız B, Şendur MAN, Paksoy N, Dirican A, Erdem D, Selam M, Tanrıverdi Ö, Paydaş S, Urakçı Z, Atağ E, Güncan S, Ürün Y, Alkan A, Kaya AO, Özyükseler DT, Taşkaynatan H, Yıldırım M, Sönmez M, Başoğlu T, Gündüz Ş, Kılıçkap S, Artaç M. Tural D, et al. Among authors: oruc k. Int J Clin Oncol. 2021 Aug;26(8):1506-1513. doi: 10.1007/s10147-021-01936-6. Epub 2021 May 23. Int J Clin Oncol. 2021. PMID: 34023933
Prognostic factors in Kaposi sarcoma, single centre experience.
Değerli E, Oruç K, Şentürk Öztaş N, Alkan Şen G, Bedir Ş, Demirci NS, Demirelli HF. Değerli E, et al. Among authors: oruc k. Australas J Dermatol. 2024 May 17. doi: 10.1111/ajd.14309. Online ahead of print. Australas J Dermatol. 2024. PMID: 38760927
14 results